# Genesky

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genesky

- Industry: Biopolymers
- Headquarters: Suzhou, China
- Website: www.geneskies.com
- Total disclosed funding: $13M
- Latest round: Series B (Dec 4, 2015)
- Investors on record: 4

## About

Established in 2014 and based in Suzhou, China, Genesky is a biotechnology company that focuses on the research and development of gene analysis technology. The company has subsidiaries including Shanghai Tianhao Biotechnology Co., Ltd., etc. Genesky's CEO, Dr. Jiang Zhengwen, has received accolades such as "Dual Innovation Talent" in Jiangsu Province and "Leading Talent" in Suzhou Industrial Park. The company was recognized as a "National High-Tech Enterprise" in 2014 and has an office established in Nanjing in 2013 to enhance customer service. In December 2015, the company closed a round of series B funding.

The company provides a comprehensive suite of genomic services and products. The company specializes in gene mutation/SNP typing, gene copy number detection, and target gene enrichment next-generation sequencing, with several proprietary technologies such as AccuCopy®, MicroSeq®, CNVplex®, iMLDR®, SNPscan®, etc. These technologies are applied in various fields including genomic sequencing, transcriptome sequencing, methylation qualitative and quantitative detection, and microbiome composition analysis.

The company generates revenue by offering precise and efficient gene detection and analysis services to research institutions, medical colleges, and bio-pharmaceutical enterprises.

## Funding rounds

- Series B, Dec 4, 2015 — Shenzhen Capital Real Estate Fund
- Series A, Jul 21, 2015, $13M — Principle Capital, Sharewin Investment, Sunland Capital
- Angel, Mar 21, 2015 — Sunland Capital

## Investors

- Sunland Capital — Angel, Series A
- Principle Capital (https://capitalatlas.ai/funds/principle-capital) — Series A
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B